title: Hyponatremia treatment guidelines 2007: expert panel recommendations.
abstract: Although hyponatremia is a common, usually mild, and relatively asymptomatic disorder of electrolytes, acute severe hyponatremia can cause substantial morbidity and mortality, particularly in patients with concomitant disease. In addition, overly rapid correction of chronic hyponatremia can cause severe neurologic deficits and death, and optimal treatment strategies for such cases are not established. An expert panel assessed the potential contributions of aquaretic nonpeptide small-molecule arginine vasopressin receptor (AVPR) antagonists to hyponatremia therapies. This review presents their conclusions, including identification of appropriate treatment populations and possible future indications for aquaretic AVPR antagonists.
authors.affiliation: Division of Endocrinology and Metabolism, Department of Medicine, Georgetown University Medical Center, Washington, District of Columbia 20007, USA. verbalis@georgetown.edu
authors.forename: Joseph G
authors.initials: JG
authors.lastname: Verbalis
authors.forename: Stephen R
authors.initials: SR
authors.lastname: Goldsmith
authors.forename: Arthur
authors.initials: A
authors.lastname: Greenberg
authors.forename: Robert W
authors.initials: RW
authors.lastname: Schrier
authors.forename: Richard H
authors.initials: RH
authors.lastname: Sterns
mesh_terms: D065092:Antidiuretic Hormone Receptor Antagonists; D006801:Humans; D007010:Hyponatremia / Q000175:diagnosis / Q000188:drug therapy* / Q000503:physiopathology; D014667:Vasopressins / Q000502:physiology
chemical_list: D065092:Antidiuretic Hormone Receptor Antagonists; D014667:Vasopressins